Roche Molecular Systems, Inc. v. Cepheid
Court of Appeals for the Federal Circuit
1Opinion of the Court
Concurring opinion filed by Circuit Judge O'Malley.
Reyna, Circuit Judge.
*1365 Appellant Roche Molecular Systems, Inc. ("Roche") owns U.S. Patent No. 5,643,723 ("the '723 patent"), titled "Detection of a Genetic Locus Encoding Resistance to Rifampin in Microbacterial Cultures and in Clinical Specimens." The United States District Court for the Northern District of California found that the asserted claims of the '723 patent are directed to patent-ineligible subject matter and are therefore invalid under 35 U.S.C. § 101 . Roche appeals from a grant of summary judgment of invalidity. We affirm .
I.…
Also in this document: Concurrence.
2Cases cited18 opinions
- Mayo Collaborative Services v. Prometheus Laboratories, Inc.Supreme Court of the United States · 2012
- Enfish, LLC v. Microsoft CorporationCourt of Appeals for the Federal Circuit · 2016
- Diamond v. ChakrabartySupreme Court of the United States · 1980
- Association for Molecular Pathology v. Myriad Genetics, Inc.Supreme Court of the United States · 2013
- Internet Patents Corporation v. Active Network, Inc.Court of Appeals for the Federal Circuit · 2015
13 more not listed; retrieve them via the Exa API.
3Cited by12 opinions
- Caredx, Inc. v. Natera, Inc.Court of Appeals for the Federal Circuit · 2022
- Illumina, Inc. v. Ariosa Diagnostics, Inc.Court of Appeals for the Federal Circuit · 2020
- Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLCCourt of Appeals for the Federal Circuit · 2019
- Illumina, Inc. v. Ariosa Diagnostics, Inc.District Court, N.D. California · 2018
- Abbott Laboratories v. Grifols Diagnostic Solutions Inc.District Court, N.D. Illinois · 2020
7 more not listed; retrieve them via the Exa API.